H. Sager Et Al. , "Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?," Medicine Science , vol.9, no.3, pp.646-652, 2020
Sager, H. Et Al. 2020. Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?. Medicine Science , vol.9, no.3 , 646-652.
Sager, H., Sancak, M., DİNÇGEZ ÇAKMAK, B., Oztas, S., Uzsezer, B., & İNCİ COŞKUN, E., (2020). Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?. Medicine Science , vol.9, no.3, 646-652.
Sager, Hakan Et Al. "Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?," Medicine Science , vol.9, no.3, 646-652, 2020
Sager, Hakan Et Al. "Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?." Medicine Science , vol.9, no.3, pp.646-652, 2020
Sager, H. Et Al. (2020) . "Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?." Medicine Science , vol.9, no.3, pp.646-652.
@article{article, author={Hakan Sager Et Al. }, title={Is enoxaparin necessary to prevent adverse pregnancy outcomes in methylenetetrahydrofolate reductase polymorphism positive recurrent pregnancy loss cases?}, journal={Medicine Science}, year=2020, pages={646-652} }